Eli Lilly & Co., a leading developer of pharmaceutical products that help people live longer, healthier and more active lives, took top honors for its support of clinical research education at the 2008 Annual Meeting of the Center for Information and Study on Clinical Research Participation (CISCRP) in June.
(DEDHAM, MA)- Eli Lilly & Co., a leading developer of pharmaceutical products that help people live longer, healthier and more active lives, took top honors for its support of clinical research education at the 2008 Annual Meeting of the Center for Information and Study on Clinical Research Participation (CISCRP) in June.
Lilly was awarded CISCRP’s Medical Heroes Awardfor its investment of people and funding in a wide span of critical initiatives including the AWARE for All Clinical Research Education program; new educational materials; and the development and testing of CISCRP’s new Medical Heroes public service campaign. The aptly named Medical Heroes Award links Lilly’s support with CISCRP’s groundbreaking efforts to transform the image of the clinical research volunteer from “guinea pig” to “medical hero.” In addition, Lilly has aided the development of CISCRP’s disease-specific DVD’s for African American and Hispanic audiences about the role of clinical research participation in improving minority health.
AstraZeneca, the Lupus Foundation, Ogilvy HealthWorld, and PharmaNet also were honored for their contributions to the development of new CISCRP Educational Materials, including: two specialized brochures for African-American and Hispanic audiences; 10 foreign language brochures for people in 12 different countries; and the creation of disease-specific DVDs about the risks and benefits of volunteering for clinical research studies.
Six Philadelphia academic medical centers and hospitals received CISCRP’s award for Outstanding Support of Public Outreach and Community Building for their work on behalf of the organization’s mission of educating and empowering people to make informed decisions about clinical research participation.
Children’s Hospital of Philadelphia, Drexel University School of Medicine, Fox Chase Cancer Center, Temple University, Thomas Jefferson University, and the University of Pennsylvania School of Medicine were recognized for their collaborative support and co-sponsorship of the highly successful AWARE for All-Philadelphia Clinical Research Education Day in April.
The highly successful program was attended by some 400 guests and provided free public workshops about health and the role of the clinical research volunteer. Many of the speakers and presenters were researchers and healthcare professionals from the co-sponsoring organizations.
The independent, non-profit organization, CISCRP, is a national leader in promoting public trust of the clinical research enterprise and raising public awareness of clinical research’s role in improving public health. To find out more, please visit www.CISCRP.org, email info@ciscrp.org, or phone 1-781-326-3400 or Toll Free: 1-888-CISCRP3 (247-2773).
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.